# Trade Mark Journal No.2026/034 21 August 2026

## WO0000001444039 (9,10,44)

Office of origin: United States of America

Date of International Registration:26 October 2018
Date of designation in the UK: 15 July 2026

Class 9
  Software and hardware for use in insulin monitoring and tracking blood glucose levels; software and hardware for use in the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; software and hardware for predicting blood glucose levels and controlling medicament delivery in the field of diabetes management.
Class 10
  Medical devices, namely, infusion pumps and peripheral devices, namely, infusion sets for diabetes care for supplying medicaments and related therapies to patients.
Class 44
  Interactive medical monitoring, reporting and alert services for infusion pump users for medical treatment purposes; providing medical information and data from devices to medical professionals and patients via a website for medical monitoring purposes; telemedicine services.

Tandem Diabetes Care, Inc.

Representative: Louis K. Ebling Thompson Hine LLP, 312 Walnut Street, , Suite 1400, Cincinnati OH 45202, UNITED STATES OF AMERICA